Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Nanoparticles release bursts of calcium to reverse multidrug resistance in tumor cells

Nanoparticles release bursts of calcium to reverse multidrug resistance in tumor cells

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Combination of peptides and antibiotics could be key to eliminating Leishmania parasites

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Combination of antibiotics and peptides could eliminate parasite-causing leishmaniasis

Cancer chemotherapy changes the function of cells that repair heart injury

Cancer chemotherapy changes the function of cells that repair heart injury

Novel liver cancer treatment could shrink tumors in a mouse model

Novel liver cancer treatment could shrink tumors in a mouse model

Brazilian red propolis contains substances with anti-cancer properties

Brazilian red propolis contains substances with anti-cancer properties

Combination of gas embolization and chemotherapy can lead to complete tumor regression

Combination of gas embolization and chemotherapy can lead to complete tumor regression

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

Researchers discover dose threshold that improves delivery of cancer-fighting drugs into a tumor

Researchers discover dose threshold that improves delivery of cancer-fighting drugs into a tumor

Proximity of mutated cells guides the initiation of tumor

Proximity of mutated cells guides the initiation of tumor

Researchers develop new nano drug that kills triple-negative breast cancer cells

Researchers develop new nano drug that kills triple-negative breast cancer cells

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Study provides insights into molecular factories of bacterial natural products

Study provides insights into molecular factories of bacterial natural products

Overcoming leukemia treatment resistance with nanoparticle drug delivery system

Overcoming leukemia treatment resistance with nanoparticle drug delivery system

Study resolves contradictions surrounding p53 gene's role in pluripotent stem cell differentiation

Study resolves contradictions surrounding p53 gene's role in pluripotent stem cell differentiation

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Researchers report a new way to stabilize liposomes

Researchers report a new way to stabilize liposomes

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

Immunotherapy before surgery may help eradicate high-risk breast cancer

Immunotherapy before surgery may help eradicate high-risk breast cancer

Graphene-based nanomedicine enables targeted cancer treatment at molecular level

Graphene-based nanomedicine enables targeted cancer treatment at molecular level